Compare Boston Scientific Corporation (BSX) vs ZIM Integrated Shipping Services Ltd (ZIM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boston Scientific Corporation vs ZIM Integrated Shipping Services Ltd — how do they compare? Boston Scientific Corporation trades at $43.58 (market cap $66.37B), while ZIM Integrated Shipping Services Ltd trades at $24.54 (market cap $2.94B). The key difference: Boston Scientific Corporation is far larger — about 22.6× ZIM Integrated Shipping Services Ltd's market cap, and ZIM Integrated Shipping Services Ltd pays a 20.16% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | ZIM | |
|---|---|---|
Market Cap | $66.37B | $2.94B |
Sector | Health | Industrials |
52-Week High | $108.14 | $29.27 |
52-Week Low | $42.63 | $12.44 |
Enterprise Value | $75.94B | $6.79B |
Dividend Yield | — | 20.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Boston Scientific (BSX) trades at $44.65, down 0.27% with bearish technical signals despite strong fundamentals. The company delivered three consecutive earnings beats with Q3-Q1 2026 EPS exceeding expectations, while revenue grew to $20.07B in 2025 with improving profit margins. Technical indicators show bearish momentum with support at $44 and resistance at $45, though Wall Street maintains 88% buy rating with $70.20 consensus target.
BSX presents a compelling value opportunity with attractive valuation multiples (P/E 18.68, P/S 3.24) and robust financial health, though near-term headwinds include competitive pressures in key segments and recent stock price decline of nearly 60% from 2025 highs. The strong analyst consensus suggests significant upside potential if execution improves.
ZIM Integrated Shipping Services (ZIM) trades at $23.80, down 0.71% on the day, amid bearish technical signals and mixed fundamental performance. The stock faces pressure from regulatory setbacks to its Hapag-Lloyd merger, though recent news highlights rival takeover interest. Financially, 2025 revenue was $6.90B with net income of $479.20M, but 2026 projections show declining profitability. Analyst consensus is split evenly between Hold and Sell, with a price target of $16.75, well below current levels.
The outlook for ZIM is cautious due to merger uncertainty and weakening earnings. Investment opportunities exist if takeover bids materialize, but risks include regulatory hurdles, freight rate volatility, and cash flow pressures. The stock's current price trades at a discount to asset value, yet analyst skepticism and bearish technicals suggest limited near-term upside without positive deal developments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →About ZIM Integrated Shipping Services Ltd
ZIM is a global container liner shipping company that employs a 'global-niche' strategy, focusing on specific trade lanes where it holds a competitive advantage. Unlike larger, asset-heavy competitors, ZIM operates an agile, charter-intensive fleet, allowing it to rapidly adjust capacity to market demand while prioritizing digitalization and specialized cargo like refrigerated (reefer) goods.
Read more on ZIM →
